NTAP
66
2
LH
45
3
AEE
64
4
MS
76
2
FTI
76
3
HBI
55
-4
NRG
52
3
ACN
49
2
AN
54
4
MRK
27
5
WEC
55
2
MAS
56
5
BRK.B
42
2
CRM
65
6
ISRG
76
2
EW
39
2
GPC
37
2
PWR
72
2
UPS
51
10
PFG
42
3
NTAP
66
2
LH
45
3
AEE
64
4
MS
76
2
FTI
76
3
HBI
55
-4
NRG
52
3
ACN
49
2
AN
54
4
MRK
27
5
WEC
55
2
MAS
56
5
BRK.B
42
2
CRM
65
6
ISRG
76
2
EW
39
2
GPC
37
2
PWR
72
2
UPS
51
10
PFG
42
3
Financhill
Back

Verrica Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
32

VRCA
Verrica Pharmaceuticals

Last Price:
1.00
Seasonality Move:
50.34%
Buy
60

BMRN
Biomarin Pharmaceutical

Last Price:
63.44
Seasonality Move:
12.47%
Sell
32
Verrica Pharmaceuticals (VRCA) is a Sell

Is Verrica Pharmaceuticals a Buy, Sell or Hold?

  • The current Verrica Pharmaceuticals [VRCA] share price is $0.99. The Score for VRCA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • VRCA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $63.45. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VRCA Stock Price Chart

What is Verrica Pharmaceuticals's stock price today?

  • The Verrica Pharmaceuticals share price today is $0.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight buying pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $63.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

VRCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 42.5 Sell
Chaikin Money Flow: 467298 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.84 - 1.54) Sell
Bollinger Bands (100): (0.73 - 5.79) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.1 Sell
Relative Strength Index (14 RSI): 33.54 Sell
Chaikin Money Flow: 933432 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.12 - 69.52) Sell
Bollinger Bands (100): (68.19 - 87.29) Sell

VRCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.89 Buy
20-day SMA: 1.09 Sell
50-day SMA: 1.38 Sell
200-day SMA: 5.03 Sell
8-day EMA: 0.92 Buy
20-day EMA: 1.06 Sell
50-day EMA: 1.65 Sell
200-day EMA: 4.01 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.96 Sell
20-day SMA: 65.96 Sell
50-day SMA: 68.96 Sell
200-day SMA: 81.18 Sell
8-day EMA: 63.79 Sell
20-day EMA: 65.7 Sell
50-day EMA: 69.97 Sell
200-day EMA: 79.54 Sell

Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.82 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Verrica Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):